CARsgen Therapeutics Holdings Limited (HKG:2171)
Hong Kong · Delayed Price · Currency is HKD 22.90
-0.10 (-0.43%)
Aug 19, 2025, 11:44 AM HKT
HKG:2171 Revenue
In the year 2024, CARsgen Therapeutics Holdings had annual revenue of 39.43M CNY. CARsgen Therapeutics Holdings had revenue of 33.09M in the half year ending December 31, 2024.
Revenue
39.43M CNY
Revenue Growth
n/a
P/S Ratio
138.31
Revenue / Employee
84.78K CNY
Employees
465
Market Cap
12.74B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 39.43M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | 25.81M | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeOne Medicines | 35.81B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| JD Health International | 71.34B |
| Innovent Biologics | 10.03B |
| Akeso | 2.26B |
| Sino Biopharmaceutical | 30.72B |
| WuXi Biologics | 19.87B |
| CSPC Pharmaceutical Group | 28.99B |